Figure 2.
Anti–SARS-CoV-2 spike antibody level stratification in patients with CLL or MBL postvaccination. Antispike level stratification after sequential vaccination were shown in patients with CLL (A) and MBL (B). Only patients with known quantitative antispike antibody levels were included.

Anti–SARS-CoV-2 spike antibody level stratification in patients with CLL or MBL postvaccination. Antispike level stratification after sequential vaccination were shown in patients with CLL (A) and MBL (B). Only patients with known quantitative antispike antibody levels were included.

Close Modal

or Create an Account

Close Modal
Close Modal